Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry and Computational Chemistry

Abstract

Progress in development of HIV-1 integrase inhibitor

Author(s): Shikha Kaushik, D. D. Bhragual, Kumari Varuna, Nitin Kumar, P. K. Sharma

AIDS (Acquired Immuno Deficiency Syndrome) has found to be most fatal syndrome. The main causative agent of AIDS is HIV-1 integrase. Incorporation of viral DNA into the host cell genome could be translated as the basis of life-long infection. Therefore, this biochemical event, catalyzed by the enzyme integrase, is a pivotal step in viral life cycle and thus worthy of being exploited to develop anti-HIV chemotherapy. The review presented on different categories of compounds that have been studied for the inhibition of the HIV-1 integrase to develop anti-HIV agents. The categories are Oligonucleotides, Curcumin Analogues, Polyhydroxylated Aromatic Compounds, Diketo Acid,) Caffeoyl-based Inhibitors, Hydrazides and Amides, Tetracycline, Depsides and Depsidones.


ankara escort
mobile bitcoin casino
Casumo no deposit bonus bitcoin nedir?